Cargando…

Molecular docking analysis of selected pyrimidine derivatives with human cyclin-dependent kinase 2

A series of pyrimidine were synthesized, characterized and evaluated for their antioxidant properties using the human cyclin-dependent kinase-2 protein model. Data shows that the pyrimidine derivatives (compound ID 4G) with para fluoro groups substitution at phenyl ring attached to the 4th position...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bharathi, R, Santhi, N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Biomedical Informatics 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882071/ https://www.ncbi.nlm.nih.gov/pubmed/35283581 http://dx.doi.org/10.6026/97320630017680

Ejemplares similares

In vitro and molecular docking studies of an anti-inflammatory scaffold with human peroxiredoxin 5 and tyrosine kinase receptor
por: Bharathi, R, et al.
Publicado: (2020)

Molecular docking of C-Jun-N-Terminal Kinase (Jnk) with amino-pyrimidine derivatives
por: Meenakumari, Krishnamoorthy, et al.
Publicado: (2020)

Insight into the Interactions between Novel Isoquinolin-1,3-Dione Derivatives and Cyclin-Dependent Kinase 4 Combining QSAR and Molecular Docking
por: Zheng, Junxia, et al.
Publicado: (2014)

Molecular docking analysis of piperine with CDK2,CDK4,Cyclin D and Cyclin T proteins
por: Rekha, Umapathy Vidhya, et al.
Publicado: (2020)

Synthesis, molecular docking and biological evaluation of bis-pyrimidine Schiff base derivatives
por: Kumar, Sanjiv, et al.
Publicado: (2017)

Synthesis and Molecular Docking Study of Novel Pyrimidine Derivatives against COVID-19
por: Alamshany, Zahra M., et al.
Publicado: (2023)

Cyclin-dependent kinases
por: Malumbres, Marcos
Publicado: (2014)

A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations
por: Susanti, Ni Made Pitri, et al.
Publicado: (2021)

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
por: Sofi, Shazia, et al.
Publicado: (2022)

Computational Exploration of Anti-cancer Potential of Flavonoids against Cyclin-Dependent Kinase 8: An In Silico Molecular Docking and Dynamic Approach
por: Rathod, Sanket, et al.
Publicado: (2022)

A cancer-derived mutation in the PSTAIRE helix of cyclin-dependent kinase 2 alters the stability of cyclin binding
por: Child, Emma S., et al.
Publicado: (2010)

Design, synthesis, antitumor evaluation, and molecular docking of novel pyrrolo[2,3-d]pyrimidine as multi-kinase inhibitors
por: Alanazi, Ashwag S., et al.
Publicado: (2023)

Novel Pyrimidine Derivatives as Potential Anticancer Agents: Synthesis, Biological Evaluation and Molecular Docking Study
por: Tylińska, Beata, et al.
Publicado: (2021)

The Cyclin-Dependent Kinase Ortholog pUL97 of Human Cytomegalovirus Interacts with Cyclins
por: Graf, Laura, et al.
Publicado: (2013)

The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer
por: Javed, Aadil, et al.
Publicado: (2023)

Functional Differentiation of Cyclins and Cyclin-Dependent Kinases in Giardia lamblia
por: Kim, Juri, et al.
Publicado: (2023)

Imidazole-4-N-acetamide Derivatives as a Novel Scaffold for Selective Targeting of Cyclin Dependent Kinases
por: Rusina, Polina, et al.
Publicado: (2023)

Cyclin-dependent kinases in C. elegans
por: Boxem, Mike
Publicado: (2006)

The Renaissance of Cyclin Dependent Kinase Inhibitors
por: Ettl, Tobias, et al.
Publicado: (2022)

Pyrimidines-Based Heterocyclic Compounds: Synthesis, Cytoxicity Evaluation and Molecular Docking
por: El-Atawy, Mohamed A., et al.
Publicado: (2022)

Regioselective Synthesis and Molecular Docking Studies of 1,5-Disubstituted 1,2,3-Triazole Derivatives of Pyrimidine Nucleobases
por: Algieri, Vincenzo, et al.
Publicado: (2022)

Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells
por: Marko, D, et al.
Publicado: (2001)

Insights from the molecular docking of withanolide derivatives to the target protein PknG from Mycobacterium tuberculosis
por: Santhi, Natchimuthu, et al.
Publicado: (2011)

Molecular Docking and Fluorescence Characterization of Benzothieno[3,2-d]pyrimidin-4-one Sulphonamide Thio-Derivatives, a Novel Class of Selective Cyclooxygenase-2 Inhibitors
por: Barone, Mariarita, et al.
Publicado: (2014)

Molecular docking analysis of doronine derivatives with human COX-2
por: Hussain, Sardar, et al.
Publicado: (2020)

Design, synthesis, in vitro anticancer, molecular docking and SAR studies of new series of pyrrolo[2,3-d]pyrimidine derivatives
por: Sroor, Farid M., et al.
Publicado: (2023)

UHRF1 phosphorylation by cyclin A2/cyclin-dependent kinase 2 is required for zebrafish embryogenesis
por: Chu, Jaime, et al.
Publicado: (2012)

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics
por: Kato, Shumei, et al.
Publicado: (2015)

Crystal structure of human cyclin-dependent kinase-2 complex with MK2 inhibitor TEI-I01800: insight into the selectivity
por: Fujino, Aiko, et al.
Publicado: (2013)

Prediction of Cyclin-Dependent Kinase Phosphorylation Substrates
por: Chang, Emmanuel J., et al.
Publicado: (2007)

Cyclin-dependent kinase control of motile ciliogenesis
por: Vladar, Eszter K, et al.
Publicado: (2018)

Cyclin-dependent kinases and rare developmental disorders
por: Colas, Pierre
Publicado: (2020)

Therapeutic targeting of transcriptional cyclin-dependent kinases
por: Galbraith, Matthew D., et al.
Publicado: (2018)

Cyclin-dependent kinase inhibitors in malignant hematopoiesis
por: Schirripa, Alessia, et al.
Publicado: (2022)

Prediction of cyclin-dependent kinase 2 inhibitor potency using the fragment molecular orbital method
por: Mazanetz, Michael P, et al.
Publicado: (2011)

The Cyclin-dependent Kinase Cdk2 Regulates Thymocyte Apoptosis
por: Hakem, Anne, et al.
Publicado: (1999)

Cyclin-dependent kinase 2 protects podocytes from apoptosis
por: Saurus, Pauliina, et al.
Publicado: (2016)

An Integrative Human Pan-Cancer Analysis of Cyclin-Dependent Kinase 1 (CDK1)
por: Liu, Xuanyou, et al.
Publicado: (2022)

Phosphorylation of cyclin O, a novel cyclin family protein containing a cyclin-like domain, is involved in the activation of cyclin-dependent kinase 2
por: KIM, DO HYUNG, et al.
Publicado: (2014)

Concomitant Presence of p16/Cyclin‐dependent Kinase 4 and Cyclin D/Cyclin‐dependent Kinase 4 omplexes in LNCaP Prostatic Cancer Cell Line
por: Itoh, Noriyuki, et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_q7r87m9tohos8f0lu5mdtb2i7r